Brian Liu
Seven Fleet Capital Management Lp
Assets Managed
$318.257M
Holdings
115
Last Quarter
2026 - Q1
Filed Date
16d ago
Growth Rate
115.39%(2Q avg: 57.7%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Seven Fleet Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 115 positions.
Assets under management
The assets under management (AUM) of Seven Fleet Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 318.257M in assets, with a quarterly growth rate of 115.39% and a 2-quarter average growth rate of 57.7%. The portfolio is managed by Brian Liu, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ur-2⤦ Cg Oncology Inc
| 30.61% | $97.418M 1.439M shares@ $67.68 avg price | New Position |
TNGX Tango Therapeutics Inc
| 3.3% | $10.502M 502,012 shares@ $20.92 avg price | Increased 133.31% |
RVMD Revolution Medicines Inc
| 2.47% | $7.857M 80,792 shares@ $97.25 avg price | Increased 22.79% |
TYRA Tyra Biosciences Inc
| 2.36% | $7.495M 195,685 shares@ $38.31 avg price | Increased 145.96% |
LQDA Liquidia Corp
| 2.23% | $7.09M 187,876 shares@ $37.74 avg price | Increased 105.86% |
AGIO Agios Pharmaceuticals Inc
| 2.23% | $7.089M 209,547 shares@ $33.83 avg price | Increased 560.25% |
IPSC Century Therapeutics Inc
| 2.1% | $6.662M 2.948M shares@ $2.27 avg price | New Position |
ELVN Enliven Therapeutics Inc
| 2.03% | $6.43M 164,030 shares@ $39.2 avg price | Increased 64.11% |
PCVX Vaxcyte Inc
| 1.99% | $6.302M 108,450 shares@ $58.11 avg price | Increased 327.56% |
ur-2⤦ Tango Therapeutics Inc
| 1.98% | $6.29M 300,648 shares@ $20.92 avg price | New Position |
1-10 of 115